TrialJournal of diabetes investigation2017

Single and multiple dose pharmacokinetics and pharmacodynamics of omarigliptin, a novel, once-weekly dipeptidyl peptidase-4 inhibitor, in healthy Japanese men.

Saori Tsuchiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.